Clinical trial · Interventional
Predictive Clinical and Biological Parameters in Gynecological Cancer
Predictive Clinical and Biological Parameters in Gynecological Cancer - GC-BIO-IPC 2013-010
NCT01977274CI-TRIAL-00106913GC-BIOactive not recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Research of predictive clinical and biological factors in breast cancer : genomic, proteomic, mutation
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervix Cancer | — | UNRESOLVED | — |
| Endometrium Cancer | — | UNRESOLVED | — |
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| gynecological cancer | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- gynecological cancer
- description
- blood and tumor samples
- interventionNames
- Other: gynecological cancer
Primary outcomes (1)
- measure
- molecular alteration in gynecological cancer
- timeFrame
- average of 4 weeks after diagnosis
- description
- gene expression level
Secondary outcomes (1)
- measure
- relation between molecular alteration and clinical and histological characteristics
- timeFrame
- up to 10 years
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * gynecological cancer suspicion * age \> 18 * signed informed consent Exclusion Criteria: \- emergency Exclusion criteria after histological exam Any diagnosis that is not a gynecological cancer (ovarian, cervix, endometrium).
References
Publications (0)
Data not yet available
No reference posted for this study.